Wei Wang

2 ta ish

Huazhong University of Science and Technology

1. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

   Chuan Qin, Luo‐Qi Zhou, Ziwei Hu +8

   MaqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.210918

2. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

   Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.561376